• Wed, November 2, 2022

by: WOPRAI

Rajvindra Gill Maintained (CRUS) at Strong Buy with Increased Target to $85 on, Nov 2nd, 2022

by: WOPRAI

Arvind Ramnani Maintained (CHGG) at Hold with Increased Target to $24 on, Nov 2nd, 2022

by: WOPRAI

Josh Baer Maintained (CHGG) at Hold with Increased Target to $24 on, Nov 2nd, 2022

by: WOPRAI

Alexander Paris Maintained (CHGG) at Buy with Increased Target to $30 on, Nov 2nd, 2022

by: WOPRAI

Mike Grondahl Maintained (CHGG) at Buy with Increased Target to $32 on, Nov 2nd, 2022

by: WOPRAI

Maxim Sytchev Maintained (CIGI) at Buy with Decreased Target to $122 on, Nov 2nd, 2022

by: WOPRAI

Kyle Peterson Maintained (CDLX) at Strong Buy with Decreased Target to $14 on, Nov 2nd, 2022

by: WOPRAI

Jeff Cantwell Maintained (CDLX) at Sell with Decreased Target to $10 on, Nov 2nd, 2022

by: WOPRAI

Brian Abrahams Maintained (BCRX) at Hold with Decreased Target to $13 on, Nov 2nd, 2022

by: WOPRAI

Liisa Bayko Upgraded (BCRX) to Buy and Held Target at $16 on, Nov 2nd, 2022

by: WOPRAI

Kurt Yinger Maintained (BCC) at Strong Buy with Decreased Target to $83 on, Nov 2nd, 2022

by: WOPRAI

Bill Katz Maintained (BEN) at Hold with Decreased Target to $20 on, Nov 2nd, 2022

by: WOPRAI

Toni Kaplan Maintained (BFAM) at Sell with Decreased Target to $57 on, Nov 2nd, 2022

by: WOPRAI

George Tong Maintained (BFAM) at Strong Buy with Decreased Target to $94 on, Nov 2nd, 2022

by: WOPRAI

Wamsi Mohan Maintained (TEL) at Strong Buy with Decreased Target to $140 on, Nov 2nd, 2022

by: WOPRAI

Puneet Souda Maintained (TECH) at Buy with Decreased Target to $125 on, Nov 2nd, 2022

by: WOPRAI

John Walsh Maintained (XYL) at Hold with Increased Target to $110 on, Nov 2nd, 2022

by: WOPRAI

Andrew Kaplowitz Maintained (XYL) at Hold with Increased Target to $109 on, Nov 2nd, 2022

by: WOPRAI

Deane Dray Maintained (XYL) at Buy with Increased Target to $114 on, Nov 2nd, 2022

by: WOPRAI

Joseph Giordano Maintained (XYL) at Buy with Increased Target to $115 on, Nov 2nd, 2022

by: WOPRAI

Jordan Alliger Maintained (XPO) at Strong Buy with Decreased Target to $40 on, Nov 2nd, 2022

by: WOPRAI

Carlos De Alba Maintained (X) at Hold with Decreased Target to $19 on, Nov 2nd, 2022

by: WOPRAI

John Glass Maintained (SYY) at Hold with Increased Target to $86 on, Nov 2nd, 2022

by: WOPRAI

John Staszak Maintained (SYY) at Strong Buy with Increased Target to $96 on, Nov 2nd, 2022

by: WOPRAI

Justin Jenkins Maintained (SUN) at Buy with Increased Target to $50 on, Nov 2nd, 2022

by: WOPRAI

Elvira Scotto Maintained (SUN) at Buy with Increased Target to $50 on, Nov 2nd, 2022

by: WOPRAI

Liam Burke Maintained (STNG) at Strong Buy with Increased Target to $65 on, Nov 2nd, 2022

by: WOPRAI

Nigel Dally Maintained (VOYA) at Buy with Increased Target to $78 on, Nov 2nd, 2022

by: WOPRAI

Andrew Jeffrey Maintained (VRSK) at Strong Buy with Decreased Target to $210 on, Nov 2nd, 2022

by: WOPRAI

Ronald Kamdem Maintained (ADC) at Buy with Decreased Target to $73 on, Nov 2nd, 2022

by: WOPRAI

John Ransom Maintained (ADUS) at Buy with Increased Target to $125 on, Nov 2nd, 2022

by: WOPRAI

Ben Hendrix Maintained (ADUS) at Buy with Increased Target to $121 on, Nov 2nd, 2022

by: WOPRAI

Quinn Bolton Maintained (AEIS) at Strong Buy with Increased Target to $88 on, Nov 2nd, 2022

by: WOPRAI

Kevin Garrigan Initiated (AEVA) at Hold and Held Target at $15 on, Nov 2nd, 2022

by: WOPRAI

Mark Dwelle Maintained (AFL) at Hold with Increased Target to $68 on, Nov 2nd, 2022

by: WOPRAI

Ann Hynes Maintained (ACHC) at Hold with Increased Target to $80 on, Nov 2nd, 2022

by: WOPRAI

Scott Fidel Maintained (ACHC) at Hold with Increased Target to $86 on, Nov 2nd, 2022

by: WOPRAI

Brian Meredith Maintained (ACGL) at Strong Buy with Increased Target to $66 on, Nov 2nd, 2022

by: WOPRAI

Mayank Tandon Downgraded (ACIW) to Hold on, Nov 2nd, 2022

by: WOPRAI

Justin Patterson Maintained (ABNB) at Buy with Decreased Target to $142 on, Nov 2nd, 2022

by: WOPRAI

Thomas Champion Maintained (ABNB) at Hold with Decreased Target to $110 on, Nov 2nd, 2022

by: WOPRAI

Eric Sheridan Maintained (ABNB) at Strong Sell with Decreased Target to $98 on, Nov 2nd, 2022

by: WOPRAI

Stephen Ju Maintained (ABNB) at Hold with Decreased Target to $154 on, Nov 2nd, 2022

by: WOPRAI

Lloyd Walmsley Maintained (ABNB) at Hold with Decreased Target to $112 on, Nov 2nd, 2022

by: WOPRAI

Colin Sebastian Maintained (ABNB) at Buy with Decreased Target to $120 on, Nov 2nd, 2022

by: WOPRAI

James Lee Maintained (ABNB) at Hold with Decreased Target to $125 on, Nov 2nd, 2022

by: WOPRAI

Brian Nowak Maintained (ABNB) at Hold with Increased Target to $110 on, Nov 2nd, 2022

by: WOPRAI

Brian Fitzgerald Maintained (ABNB) at Buy with Decreased Target to $165 on, Nov 2nd, 2022

Gregory Renza Maintained (APTO) at Buy with Decreased Target to $75 on, Nov 2nd, 2022

Gregory Renza of RBC Capital, Maintained "Aptose Biosciences Inc." (APTO) at Buy with Decreased Target from $90 to $75 on, Nov 2nd, 2022.

Gregory, nor any peers, have made any analyst calls on APTO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍